labetalol has been researched along with Asystole in 9 studies
Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The rare complication of asystole with beta-adrenergic blockade by labetalol following electroconvulsive therapy (ECT) is described with a literature review of cardiac mechanisms (33 references)." | 4.79 | Asystole with electroconvulsive therapy. ( Kaufman, KR, 1994) |
| "We report the specifics of 12 cases of severe hypertension after the intraoperative use of topical phenylephrine, submucosal epinephrine, or both." | 4.79 | Cardiopulmonary compromise after use of topical and submucosal alpha-agonists: possible added complication by the use of beta-blocker therapy. ( Carpenter, RL; Guertin, SR; Kalyanaraman, M; McGlew, MJ, 1997) |
| "Patients in cardiac arrest are often taking medications affecting adrenergic activity such as the beta blocker metoprolol and the combined alpha and beta blocker, labetalol." | 1.38 | Beta-blockade causes a reduction in the frequency spectrum of VF but improves resuscitation outcome: A potential limitation of quantitative waveform measures. ( Niemann, J; Rosborough, JP; Shah, AP; Sherman, L; Youngquist, ST, 2012) |
| "We report a case of cardiac arrest after uncomplicated regional anesthesia in a patient with scleroderma who received labetalol and metoclopramide after surgery." | 1.31 | Cardiac arrest after labetalol and metoclopramide administration in a patient with scleroderma. ( Cutter, T; Sweitzer, B; Tung, A, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bryson, EO | 1 |
| Kellner, CH | 1 |
| Ahle, GM | 1 |
| Liebman, LS | 1 |
| Sherman, L | 1 |
| Niemann, J | 1 |
| Youngquist, ST | 1 |
| Shah, AP | 1 |
| Rosborough, JP | 1 |
| Tung, A | 1 |
| Sweitzer, B | 1 |
| Cutter, T | 1 |
| Schwartz, D | 1 |
| VadeBoncouer, T | 1 |
| Weinberg, G | 1 |
| Diamond, AL | 1 |
| Callison, RC | 1 |
| Shokri, J | 1 |
| Cruz-Flores, S | 1 |
| Kinsella, LJ | 1 |
| Kaufman, KR | 1 |
| Kalyanaraman, M | 1 |
| Carpenter, RL | 1 |
| McGlew, MJ | 1 |
| Guertin, SR | 1 |
| Dannon, PN | 1 |
| Iancu, I | 1 |
| Hirschmann, S | 1 |
| Ross, P | 1 |
| Dolberg, OT | 1 |
| Grunhaus, L | 1 |
| Hunter, JM | 1 |
2 reviews available for labetalol and Asystole
| Article | Year |
|---|---|
Asystole with electroconvulsive therapy.
Topics: Adult; Electroconvulsive Therapy; Heart Arrest; Humans; Labetalol; Male | 1994 |
Cardiopulmonary compromise after use of topical and submucosal alpha-agonists: possible added complication by the use of beta-blocker therapy.
Topics: Administration, Intranasal; Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Child; Epinephri | 1997 |
1 trial available for labetalol and Asystole
| Article | Year |
|---|---|
Labetalol does not lengthen asystole during electroconvulsive therapy.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adult; Aged; Blood Pressure; Bradycardia; Combi | 1998 |
6 other studies available for labetalol and Asystole
| Article | Year |
|---|---|
Asystole during electroconvulsive therapy.
Topics: Adrenergic beta-Antagonists; Depressive Disorder, Major; Electrocardiography; Electroconvulsive Ther | 2014 |
Beta-blockade causes a reduction in the frequency spectrum of VF but improves resuscitation outcome: A potential limitation of quantitative waveform measures.
Topics: Adrenergic beta-Antagonists; Animals; Cardiopulmonary Resuscitation; Confidence Intervals; Disease M | 2012 |
Cardiac arrest after labetalol and metoclopramide administration in a patient with scleroderma.
Topics: Adult; Antiemetics; Antihypertensive Agents; Female; Heart Arrest; Humans; Labetalol; Metoclopramide | 2002 |
Was case report a case of unrecognized local anesthetic toxicity?
Topics: Adrenergic beta-Antagonists; Adult; Anesthetics, Local; Bupivacaine; Female; Heart Arrest; Humans; L | 2003 |
Paroxysmal sympathetic storm.
Topics: Adrenergic beta-Antagonists; Adult; Analgesics, Opioid; Brain Injuries; Fever; Heart Arrest; Humans; | 2005 |
Synergism between halothane and labetalol.
Topics: Anesthesia, Inhalation; Depression, Chemical; Drug Synergism; Ethanolamines; Female; Halothane; Hear | 1979 |